The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Endoscopic Retrograde Cholangiopancreatography Devices Market Research Report 2025
Synopsis
Endoscopic Retrograde Cholangiopancreatography (ERCP) devices are medical instruments and tools used in the diagnostic and therapeutic procedure known as ERCP. ERCP is a specialized endoscopic technique used to visualize and treat disorders of the bile ducts, pancreatic duct, and gallbladder. The procedure involves the use of an endoscope, a flexible tube with a light and camera at the tip, which is passed through the mouth, esophagus, stomach, and into the duodenum.
The global Endoscopic Retrograde Cholangiopancreatography Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The demand for ERCP devices is influenced by the overall number of ERCP procedures performed globally. Factors such as the prevalence of biliary and pancreatic disorders, the aging population, and the adoption of minimally invasive procedures contribute to the growth of ERCP procedures and, consequently, the demand for related devices.
This report aims to provide a comprehensive presentation of the global market for Endoscopic Retrograde Cholangiopancreatography Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endoscopic Retrograde Cholangiopancreatography Devices.
Report Scope
The Endoscopic Retrograde Cholangiopancreatography Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Endoscopic Retrograde Cholangiopancreatography Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endoscopic Retrograde Cholangiopancreatography Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boston Scientific
Cook Medical
Olympus
CONMED
Hobbs Medical
Merit Endotek
Telemed Systems
STERIS
Segment by Type
Biliary Stone Removal Basket
Biliary Dilation Balloon
Biliary and Pancreatic Stent
Biliary Lithotripter
ERCP Cannula
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Endoscopic Retrograde Cholangiopancreatography Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Endoscopic Retrograde Cholangiopancreatography Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Endoscopic Retrograde Cholangiopancreatography (ERCP) devices are medical instruments and tools used in the diagnostic and therapeutic procedure known as ERCP. ERCP is a specialized endoscopic technique used to visualize and treat disorders of the bile ducts, pancreatic duct, and gallbladder. The procedure involves the use of an endoscope, a flexible tube with a light and camera at the tip, which is passed through the mouth, esophagus, stomach, and into the duodenum.
The global Endoscopic Retrograde Cholangiopancreatography Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The demand for ERCP devices is influenced by the overall number of ERCP procedures performed globally. Factors such as the prevalence of biliary and pancreatic disorders, the aging population, and the adoption of minimally invasive procedures contribute to the growth of ERCP procedures and, consequently, the demand for related devices.
This report aims to provide a comprehensive presentation of the global market for Endoscopic Retrograde Cholangiopancreatography Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endoscopic Retrograde Cholangiopancreatography Devices.
Report Scope
The Endoscopic Retrograde Cholangiopancreatography Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Endoscopic Retrograde Cholangiopancreatography Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endoscopic Retrograde Cholangiopancreatography Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boston Scientific
Cook Medical
Olympus
CONMED
Hobbs Medical
Merit Endotek
Telemed Systems
STERIS
Segment by Type
Biliary Stone Removal Basket
Biliary Dilation Balloon
Biliary and Pancreatic Stent
Biliary Lithotripter
ERCP Cannula
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Endoscopic Retrograde Cholangiopancreatography Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Endoscopic Retrograde Cholangiopancreatography Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Endoscopic Retrograde Cholangiopancreatography Devices Market Overview
1.1 Product Overview and Scope of Endoscopic Retrograde Cholangiopancreatography Devices
1.2 Endoscopic Retrograde Cholangiopancreatography Devices Segment by Type
1.2.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Value Comparison by Type (2024-2030)
1.2.2 Biliary Stone Removal Basket
1.2.3 Biliary Dilation Balloon
1.2.4 Biliary and Pancreatic Stent
1.2.5 Biliary Lithotripter
1.2.6 ERCP Cannula
1.3 Endoscopic Retrograde Cholangiopancreatography Devices Segment by Application
1.3.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Size Estimates and Forecasts
1.4.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue 2019-2030
1.4.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales 2019-2030
1.4.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Endoscopic Retrograde Cholangiopancreatography Devices Market Competition by Manufacturers
2.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Average Price by Manufacturers (2019-2024)
2.4 Global Endoscopic Retrograde Cholangiopancreatography Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Endoscopic Retrograde Cholangiopancreatography Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Endoscopic Retrograde Cholangiopancreatography Devices, Product Type & Application
2.7 Endoscopic Retrograde Cholangiopancreatography Devices Market Competitive Situation and Trends
2.7.1 Endoscopic Retrograde Cholangiopancreatography Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Endoscopic Retrograde Cholangiopancreatography Devices Players Market Share by Revenue
2.7.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Endoscopic Retrograde Cholangiopancreatography Devices Retrospective Market Scenario by Region
3.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Global Endoscopic Retrograde Cholangiopancreatography Devices Sales by Region: 2019-2030
3.2.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales by Region: 2019-2024
3.2.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales by Region: 2025-2030
3.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Region: 2019-2030
3.3.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Region: 2019-2024
3.3.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Region: 2025-2030
3.4 North America Endoscopic Retrograde Cholangiopancreatography Devices Market Facts & Figures by Country
3.4.1 North America Endoscopic Retrograde Cholangiopancreatography Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Endoscopic Retrograde Cholangiopancreatography Devices Sales by Country (2019-2030)
3.4.3 North America Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Endoscopic Retrograde Cholangiopancreatography Devices Market Facts & Figures by Country
3.5.1 Europe Endoscopic Retrograde Cholangiopancreatography Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Endoscopic Retrograde Cholangiopancreatography Devices Sales by Country (2019-2030)
3.5.3 Europe Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Endoscopic Retrograde Cholangiopancreatography Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Endoscopic Retrograde Cholangiopancreatography Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Endoscopic Retrograde Cholangiopancreatography Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Endoscopic Retrograde Cholangiopancreatography Devices Market Facts & Figures by Country
3.7.1 Latin America Endoscopic Retrograde Cholangiopancreatography Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Endoscopic Retrograde Cholangiopancreatography Devices Sales by Country (2019-2030)
3.7.3 Latin America Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales by Type (2019-2030)
4.1.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales by Type (2019-2024)
4.1.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales by Type (2025-2030)
4.1.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales Market Share by Type (2019-2030)
4.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Type (2019-2030)
4.2.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Type (2019-2024)
4.2.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Type (2025-2030)
4.2.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue Market Share by Type (2019-2030)
4.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales by Application (2019-2030)
5.1.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales by Application (2019-2024)
5.1.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales by Application (2025-2030)
5.1.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales Market Share by Application (2019-2030)
5.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Application (2019-2030)
5.2.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Application (2019-2024)
5.2.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Application (2025-2030)
5.2.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue Market Share by Application (2019-2030)
5.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Corporation Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific Endoscopic Retrograde Cholangiopancreatography Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boston Scientific Endoscopic Retrograde Cholangiopancreatography Devices Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Cook Medical
6.2.1 Cook Medical Corporation Information
6.2.2 Cook Medical Description and Business Overview
6.2.3 Cook Medical Endoscopic Retrograde Cholangiopancreatography Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Cook Medical Endoscopic Retrograde Cholangiopancreatography Devices Product Portfolio
6.2.5 Cook Medical Recent Developments/Updates
6.3 Olympus
6.3.1 Olympus Corporation Information
6.3.2 Olympus Description and Business Overview
6.3.3 Olympus Endoscopic Retrograde Cholangiopancreatography Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Olympus Endoscopic Retrograde Cholangiopancreatography Devices Product Portfolio
6.3.5 Olympus Recent Developments/Updates
6.4 CONMED
6.4.1 CONMED Corporation Information
6.4.2 CONMED Description and Business Overview
6.4.3 CONMED Endoscopic Retrograde Cholangiopancreatography Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CONMED Endoscopic Retrograde Cholangiopancreatography Devices Product Portfolio
6.4.5 CONMED Recent Developments/Updates
6.5 Hobbs Medical
6.5.1 Hobbs Medical Corporation Information
6.5.2 Hobbs Medical Description and Business Overview
6.5.3 Hobbs Medical Endoscopic Retrograde Cholangiopancreatography Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hobbs Medical Endoscopic Retrograde Cholangiopancreatography Devices Product Portfolio
6.5.5 Hobbs Medical Recent Developments/Updates
6.6 Merit Endotek
6.6.1 Merit Endotek Corporation Information
6.6.2 Merit Endotek Description and Business Overview
6.6.3 Merit Endotek Endoscopic Retrograde Cholangiopancreatography Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Merit Endotek Endoscopic Retrograde Cholangiopancreatography Devices Product Portfolio
6.6.5 Merit Endotek Recent Developments/Updates
6.7 Telemed Systems
6.6.1 Telemed Systems Corporation Information
6.6.2 Telemed Systems Description and Business Overview
6.6.3 Telemed Systems Endoscopic Retrograde Cholangiopancreatography Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Telemed Systems Endoscopic Retrograde Cholangiopancreatography Devices Product Portfolio
6.7.5 Telemed Systems Recent Developments/Updates
6.8 STERIS
6.8.1 STERIS Corporation Information
6.8.2 STERIS Description and Business Overview
6.8.3 STERIS Endoscopic Retrograde Cholangiopancreatography Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 STERIS Endoscopic Retrograde Cholangiopancreatography Devices Product Portfolio
6.8.5 STERIS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Endoscopic Retrograde Cholangiopancreatography Devices Industry Chain Analysis
7.2 Endoscopic Retrograde Cholangiopancreatography Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Endoscopic Retrograde Cholangiopancreatography Devices Production Mode & Process
7.4 Endoscopic Retrograde Cholangiopancreatography Devices Sales and Marketing
7.4.1 Endoscopic Retrograde Cholangiopancreatography Devices Sales Channels
7.4.2 Endoscopic Retrograde Cholangiopancreatography Devices Distributors
7.5 Endoscopic Retrograde Cholangiopancreatography Devices Customers
8 Endoscopic Retrograde Cholangiopancreatography Devices Market Dynamics
8.1 Endoscopic Retrograde Cholangiopancreatography Devices Industry Trends
8.2 Endoscopic Retrograde Cholangiopancreatography Devices Market Drivers
8.3 Endoscopic Retrograde Cholangiopancreatography Devices Market Challenges
8.4 Endoscopic Retrograde Cholangiopancreatography Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
